{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,14]],"date-time":"2026-11-14T00:23:09Z","timestamp":1794615789040,"version":"4.9.1"},"reference-count":41,"publisher":"Ovid Technologies (Wolters Kluwer Health)","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"abstract":"<jats:title>Abstract:<\/jats:title>\n                  <jats:p>Granulocyte colony-stimulating factor (G-CSF) is known to induce several cutaneous neutrophilic reactions, including Sweet syndrome-like eruptions, neutrophilic panniculitis, neutrophilic eccrine hidradenitis, and sterile folliculitis. We report the case of a male patient with an unclassified malformative syndrome and chronic neutropenia who developed acute painful suppurative nodular scalp lesions while receiving long-term G-CSF therapy and during a period of marked neutrophilia. Histopathological examination showed superficial and deep suppurative neutrophilic folliculitis with follicular abscess formation, follicular epithelial destruction, focal perifollicular fibrosis, neutrophilic epidermotropism, and sparse Gram-positive cocci within deep follicular abscesses. Because the clinical course was acute and a chronic relapsing course, tufted hairs\/polytrichia, and unequivocal irreversible cicatricial alopecia were not documented, we do not regard the findings as sufficient for a definitive diagnosis of classic folliculitis decalvans. Rather, the case is best interpreted as G-CSF\u2013associated destructive neutrophilic folliculitis of the scalp with folliculitis decalvans-like features. This case broadens the spectrum of G-CSF\u2013associated follicular reactions and supports the possibility that G-CSF\u2013driven neutrophilia may facilitate severe folliculocentric neutrophilic inflammation, particularly in the setting of bacterial colonization or infection and altered host immunity.<\/jats:p>","DOI":"10.1097\/dad.0000000000003465","type":"journal-article","created":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T14:00:37Z","timestamp":1792677637000},"update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":1,"title":["G-CSF\u2013Associated Superficial and Deep Neutrophilic Folliculitis of the Scalp with Folliculitis Decalvans-Like Features"],"prefix":"10.1097","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-6617-2364","authenticated-orcid":false,"given":"Angel","family":"Fernandez-Flores","sequence":"first","affiliation":[{"name":"Department of Cellular Pathology, University Hospital El Bierzo, Ponferrada, Spain;"},{"name":"Department of Cellular Pathology, Hospital de la Reina, Ponferrada, Spain; and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Isidro","family":"Rego","sequence":"additional","affiliation":[{"name":"Department of Dermatology, University Hospital El Bierzo, Ponferrada, Spain."}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2026,10,22]]},"reference":[{"key":"R1-20261022","doi-asserted-by":"crossref","first-page":"916","DOI":"10.1111\/j.1365-2230.2010.03852.x","article-title":"Folliculitis decalvans associated with erlotinib","volume":"35","author":"Hoekzema","year":"2010","journal-title":"Clin Exp Dermatol"},{"key":"R2-20261022","doi-asserted-by":"crossref","first-page":"924","DOI":"10.1111\/ced.12083","article-title":"Erlotinib-induced folliculitis decalvans","volume":"38","author":"Keith","year":"2013","journal-title":"Clin Exp Dermatol"},{"key":"R3-20261022","doi-asserted-by":"crossref","first-page":"e2024161","DOI":"10.5826\/dpc.1403a161","article-title":"Folliculitis Decalvans due to epidermal growth factor inhibitor","volume":"14","author":"Alessandrini","year":"2024","journal-title":"Dermatol Pract Concept"},{"key":"R4-20261022","doi-asserted-by":"crossref","first-page":"e2023180","DOI":"10.5826\/dpc.1303a180","article-title":"Folliculitis-Decalvans like alopecia during treatment with EGFR inhibitors for lung cancer: a case series of 6 patients","volume":"13","author":"Starace","year":"2023","journal-title":"Dermatol Pract Concept"},{"key":"R5-20261022","doi-asserted-by":"crossref","first-page":"942","DOI":"10.1097\/CAD.0000000000001494","article-title":"EGFR inhibitor-induced folliculitis decalvans: a case series and management guidelines","volume":"34","author":"Nowaczyk","year":"2023","journal-title":"Anticancer Drugs"},{"key":"R6-20261022","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1111\/j.1365-2133.1992.tb08061.x","article-title":"Widespread folliculitis induced by human granulocyte-colony-stimulating factor therapy","volume":"127","author":"Ostlere","year":"1992","journal-title":"Br J Dermatol"},{"key":"R7-20261022","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1038\/nrc2843","article-title":"The colony-stimulating factors and cancer","volume":"10","author":"Metcalf","year":"2010","journal-title":"Nat Rev Cancer"},{"key":"R8-20261022","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1182\/blood.V88.3.761.bloodjournal883761","article-title":"Molecular analysis of the granulocyte colony-stimulating factor receptor","volume":"88","author":"Avalos","year":"1996","journal-title":"Blood"},{"key":"R9-20261022","doi-asserted-by":"crossref","first-page":"918","DOI":"10.1016\/S0190-9622(96)90080-8","article-title":"Trimethoprim-sulfamethoxazole-associated acute febrile neutrophilic dermatosis: case report and review of drug-induced Sweet's syndrome","volume":"34","author":"Walker","year":"1996","journal-title":"J Am Acad Dermatol"},{"key":"R10-20261022","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1186\/1750-1172-2-34","article-title":"Sweet's syndrome--a comprehensive review of an acute febrile neutrophilic dermatosis","volume":"2","author":"Cohen","year":"2007","journal-title":"Orphanet J Rare Dis"},{"key":"R11-20261022","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1002\/(SICI)1096-8652(199906)61:2<126::AID-AJH9>3.0.CO;2-8","article-title":"Case of granulocyte colony-stimulating factor-induced Sweet's syndrome","volume":"61","author":"Arbetter","year":"1999","journal-title":"Am J Hematol"},{"issue":"suppl 1","key":"R12-20261022","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1007\/s12288-014-0420-2","article-title":"Granulocyte colony stimulating factor induced sweet's syndrome following autologous transplantation in a child with relapsed acute myeloblastic leukemia","volume":"30","author":"Kaya","year":"2014","journal-title":"Indian J Hematol Blood Transfus"},{"key":"R13-20261022","doi-asserted-by":"crossref","first-page":"1275","DOI":"10.1111\/j.1365-4632.2012.05744.x","article-title":"Pegfilgrastim-induced Sweet's syndrome: a case report","volume":"53","author":"Machan","year":"2014","journal-title":"Int J Dermatol"},{"key":"R14-20261022","first-page":"422","article-title":"Deep Sweet syndrome secondary to pegfilgrastim","volume":"21","author":"Clarey","year":"2022","journal-title":"J Drugs Dermatol"},{"key":"R15-20261022","doi-asserted-by":"crossref","first-page":"901","DOI":"10.1016\/j.jaad.2004.12.028","article-title":"Bullous Sweet's syndrome in congenital neutropenia: association with pegfilgrastim","volume":"52","author":"Draper","year":"2005","journal-title":"J Am Acad Dermatol"},{"key":"R16-20261022","doi-asserted-by":"crossref","first-page":"685","DOI":"10.2340\/00015555-3170","article-title":"Localized pegfilgrastim-induced neutrophilic dermatosis with tissue G-CSF expression: a mimicker of Sweet's syndrome","volume":"99","author":"Ichiki","year":"2019","journal-title":"Acta Derm Venereol"},{"key":"R17-20261022","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1111\/cup.12042","article-title":"Sweet's syndrome with subcutaneous involvement associated with pegfilgrastim treatment: first reported case","volume":"40","author":"Llamas-Velasco","year":"2013","journal-title":"J Cutan Pathol"},{"key":"R18-20261022","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1046\/j.1365-2133.1998.02389.x","article-title":"Neutrophilic eccrine hidradenitis induced by granulocyte colony-stimulating factor","volume":"139","author":"Bachmeyer","year":"1998","journal-title":"Br J Dermatol"},{"key":"R19-20261022","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1002\/ccr3.1932","article-title":"Neutrophilic eccrine hidradenitis secondary to pegfilgrastim in a patient with synovial sarcoma","volume":"7","author":"Puar","year":"2019","journal-title":"Clin Case Rep"},{"key":"R20-20261022","doi-asserted-by":"crossref","first-page":"e9114","DOI":"10.1002\/ccr3.9114","article-title":"Neutrophilic eccrine hidradenitis from granulocyte-stimulating factor in a patient with ANCA vasculitis","volume":"12","author":"Chaisrimaneepan","year":"2024","journal-title":"Clin Case Rep"},{"key":"R21-20261022","doi-asserted-by":"crossref","first-page":"181","DOI":"10.3109\/15569520903178208","article-title":"Rash associated with the use of pegylated filgrastim in a patient with advanced pancreatic cancer","volume":"28","author":"Bustillo","year":"2009","journal-title":"Cutan Ocul Toxicol"},{"key":"R22-20261022","doi-asserted-by":"crossref","first-page":"4807","DOI":"10.3390\/ijms25094807","article-title":"Balancing benefits and risks: a literature review on hypersensitivity reactions to human G-CSF (Granulocyte colony-stimulating factor)","volume":"25","author":"Bumb\u0103cea","year":"2024","journal-title":"Int J Mol Sci"},{"key":"R23-20261022","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1111\/j.1600-0560.1998.tb01741.x","article-title":"Histopathology of cutaneous reaction to granulocyte colony-stimulating factor: another pseudomalignancy","volume":"25","author":"Fari\u00f1a","year":"1998","journal-title":"J Cutan Pathol"},{"key":"R24-20261022","doi-asserted-by":"crossref","first-page":"5216","DOI":"10.1002\/j.1460-2075.1995.tb00206.x","article-title":"Expression of a dominant negative mutant of epidermal growth factor receptor in the epidermis of transgenic mice elicits striking alterations in hair follicle development and skin structure","volume":"14","author":"Murillas","year":"1995","journal-title":"Embo j"},{"key":"R25-20261022","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1016\/j.isci.2019.04.018","article-title":"EGFR controls hair shaft differentiation in a p53-Independent manner","volume":"15","author":"Amberg","year":"2019","journal-title":"iScience"},{"key":"R26-20261022","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/j.jdermsci.2013.05.009","article-title":"Recent advances in the epidermal growth factor receptor\/ligand system biology on skin homeostasis and keratinocyte stem cell regulation","volume":"72","author":"Nanba","year":"2013","journal-title":"J Dermatol Sci"},{"key":"R27-20261022","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1186\/s12885-020-07685-5","article-title":"EGFR inhibitors switch keratinocytes from a proliferative to a differentiative phenotype affecting epidermal development and barrier function","volume":"21","author":"Joly-Tonetti","year":"2021","journal-title":"BMC Cancer"},{"key":"R28-20261022","doi-asserted-by":"crossref","first-page":"1179","DOI":"10.1016\/S0190-9622(89)70325-X","article-title":"Steroid acne","volume":"21","author":"Hurwitz","year":"1989","journal-title":"J Am Acad Dermatol"},{"key":"R29-20261022","first-page":"26","article-title":"Acneform eruptions and antitubercular drugs","volume":"61","author":"Sharma","year":"1995","journal-title":"Indian J Dermatol Venereol Leprol"},{"key":"R30-20261022","doi-asserted-by":"crossref","first-page":"3","DOI":"10.2165\/00128071-200405010-00002","article-title":"Cutaneous adverse effects of lithium: epidemiology and management","volume":"5","author":"Yeung","year":"2004","journal-title":"Am J Clin Dermatol"},{"key":"R31-20261022","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1111\/cup.14310","article-title":"Acute iododerma presenting as cryptococcoid neutrophilic dermatosis: a clinicopathological pitfall and interesting findings gleaned from a review of the literature","volume":"50","author":"Lim","year":"2023","journal-title":"J Cutan Pathol"},{"key":"R32-20261022","first-page":"338","article-title":"Acne and phenytoin","volume":"139","author":"Frentz","year":"1977","journal-title":"Ugeskr Laeger"},{"key":"R33-20261022","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1159\/000088511","article-title":"Sirolimus-induced acneiform eruption","volume":"211","author":"Kunzle","year":"2005","journal-title":"Dermatology"},{"key":"R34-20261022","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1001\/archderm.137.3.373","article-title":"Folliculitis decalvans and tufted folliculitis are specific infective diseases that may lead to scarring, but are not a subset of central centrifugal scarring alopecia","volume":"137","author":"Powell","year":"2001","journal-title":"Arch Dermatol"},{"key":"R35-20261022","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1111\/j.1529-8019.2008.00204.x","article-title":"Folliculitis decalvans","volume":"21","author":"Otberg","year":"2008","journal-title":"Dermatol Ther"},{"key":"R36-20261022","doi-asserted-by":"crossref","first-page":"570","DOI":"10.2340\/00015555-2924","article-title":"Inflammasome activation characterizes lesional skin of Folliculitis decalvans","volume":"98","author":"Eyraud","year":"2018","journal-title":"Acta Derm Venereol"},{"key":"R37-20261022","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1016\/S0738-081X(00)00132-2","article-title":"Cicatricial alopecia: clinico-pathological findings and treatment","volume":"19","author":"Whiting","year":"2001","journal-title":"Clin Dermatol"},{"issue":"suppl 2","key":"R38-20261022","first-page":"19","article-title":"Hair follicle biology and topical minoxidil: possible mechanisms of action","volume":"175","author":"Headington","year":"1987","journal-title":"Dermatologica"},{"key":"R39-20261022","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1038\/nature14052","article-title":"Commensal-dendritic-cell interaction specifies a unique protective skin immune signature","volume":"520","author":"Naik","year":"2015","journal-title":"Nature"},{"key":"R40-20261022","doi-asserted-by":"crossref","first-page":"526","DOI":"10.1309\/NG60Y7V0WNUFH4LA","article-title":"Immunopathogenesis of folliculitis decalvans: clues in early lesions","volume":"130","author":"Chiarini","year":"2008","journal-title":"Am J Clin Pathol"},{"key":"R41-20261022","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1038\/nri3010","article-title":"Immunity against Staphylococcus aureus cutaneous infections","volume":"11","author":"Miller","year":"2011","journal-title":"Nat Rev Immunol"}],"container-title":["The American Journal of Dermatopathology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.1097\/DAD.0000000000003465","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T14:00:43Z","timestamp":1792677643000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/10.1097\/DAD.0000000000003465"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,10,22]]},"references-count":41,"URL":"https:\/\/doi.org\/10.1097\/dad.0000000000003465","relation":{},"ISSN":["0193-1091","1533-0311"],"issn-type":[{"value":"0193-1091","type":"print"},{"value":"1533-0311","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,10,22]]}}}